ARS Pharmaceuticals, Inc. is a pharmaceutical company committed to developing patient-friendly treatments to address serious issues related to needle-related risks and device ease of use. The company has introduced 'neffy,' the first and only FDA-approved needle-free epinephrine nasal spray, providing an alternative delivery method for epinephrine that is easy to carry and administer. ARS Pharma aims to make these treatments accessible and affordable through savings and support programs. The company is focused on innovative therapies that empower patients and caregivers, striving to offer practical options for epinephrine delivery.